These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design. Optimal Therapy in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Dickstein K; Kjekshus J Am J Cardiol; 1999 Feb; 83(4):477-81. PubMed ID: 10073846 [TBL] [Abstract][Full Text] [Related]
7. Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (The OPTIMAAL Trial). OPTIMAAL Trial Steering Committee and Investigators. Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan. Dickstein K; Kjekshus J; Am J Cardiol; 2001 Mar; 87(6):766-71, A7. PubMed ID: 11249900 [TBL] [Abstract][Full Text] [Related]
8. [Angiotensin receptor antagonist for therapy of patients with hypertension]. Rakugi H; Ogihara T Nihon Rinsho; 1997 Aug; 55(8):2075-80. PubMed ID: 9284426 [TBL] [Abstract][Full Text] [Related]
10. Losartan inhibits myosin isoform shift after myocardial infarction in rats. Zhang ML; Elkassem S; Davidoff AW; Saito K; ter Keurs HE Mol Cell Biochem; 2003 Sep; 251(1-2):111-7. PubMed ID: 14575312 [TBL] [Abstract][Full Text] [Related]
11. [ACE inhibitors or AT1 receptor antagonists?]. Riegger GA Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045 [No Abstract] [Full Text] [Related]
12. [Cardiologic and diabetologic aspects of therapy with angiotensin receptor blocking agents]. Winkler G; Jermendy G; Matos L Orv Hetil; 2003 Sep; 144(38):1861-7. PubMed ID: 14596024 [TBL] [Abstract][Full Text] [Related]
13. [Interview with the author of ELITE II. Cave: small studies of fatal illnesses]. Pitt B MMW Fortschr Med; 1999 Nov; 141(47):6. PubMed ID: 10912156 [No Abstract] [Full Text] [Related]
14. Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats. Martínez LA; Villalobos-Molina R Arch Med Res; 2003; 34(5):357-61. PubMed ID: 14602500 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists for heart failure. Struthers AD Heart; 1998 Jul; 80(1):5-6. PubMed ID: 9764049 [No Abstract] [Full Text] [Related]
16. AII antagonists in hypertension, heart failure, and diabetic nephropathy: focus on losartan. Ferrario C; Abdelhamed AI; Moore M Curr Med Res Opin; 2004 Mar; 20(3):279-93. PubMed ID: 15025837 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH; Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711 [TBL] [Abstract][Full Text] [Related]
18. [A-II blocker or ACE inhibitor in heart failure? Captopril can't be beat]. Einecke D MMW Fortschr Med; 1999 Nov; 141(47):4-5. PubMed ID: 10912155 [No Abstract] [Full Text] [Related]
19. [The RENAAL Study. Effect of losartan on diabetic nephropathy]. Kuhlmann MK; Köhler H Internist (Berl); 2002 May; 43(5):675-7. PubMed ID: 12085539 [No Abstract] [Full Text] [Related]